FocusDyslipidemia

It Ain’t Over ‘Til the Fat Lady Sings

Science Translational Medicine  22 Aug 2012:
Vol. 4, Issue 148, pp. 148fs30
DOI: 10.1126/scitranslmed.3004445

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The antiatherogenic drug nicotinic acid (niacin) has antidyslipidemic effects independent of free fatty acid suppression mediated by its receptor HCA2 (GPR109A) (Lauring et al., this issue).

View Full Text